Healthpeak Properties (NYSE:DOC) Stock Rating Upgraded by BNP Paribas

Healthpeak Properties (NYSE:DOC) was upgraded by stock analysts at BNP Paribas from a “neutral” rating to an “outperform” rating in a research note issued to investors on Friday, Marketbeat.com reports. The firm presently has a $21.00 target price on the real estate investment trust’s stock, up from their previous target price of $19.00. BNP Paribas’ price target would indicate a potential upside of 11.70% from the stock’s previous close.

A number of other analysts have also recently commented on DOC. Compass Point cut their target price on Healthpeak Properties from $19.00 to $18.00 and set a “buy” rating on the stock in a research report on Tuesday, January 2nd. Royal Bank of Canada increased their price target on shares of Healthpeak Properties from $21.00 to $22.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 10th. Bank of America upgraded shares of Healthpeak Properties from an “underperform” rating to a “buy” rating and raised their price objective for the company from $18.00 to $25.00 in a research note on Monday, April 1st. Wells Fargo & Company assumed coverage on shares of Healthpeak Properties in a research note on Monday, March 25th. They issued an “equal weight” rating and a $19.00 price objective on the stock. Finally, KeyCorp reiterated a “sector weight” rating on shares of Healthpeak Properties in a report on Friday, January 5th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, Healthpeak Properties has a consensus rating of “Moderate Buy” and a consensus price target of $18.36.

Healthpeak Properties Stock Up 2.5 %

Shares of NYSE DOC traded up $0.46 during mid-day trading on Friday, reaching $18.80. The company had a trading volume of 3,010,423 shares, compared to its average volume of 7,223,459. Healthpeak Properties has a 52-week low of $15.24 and a 52-week high of $22.38. The stock has a market cap of $13.34 billion, a P/E ratio of 33.50, a PEG ratio of 1.84 and a beta of 1.02. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.00. The firm has a 50 day simple moving average of $16.52 and a two-hundred day simple moving average of $13.69.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Parallel Advisors LLC increased its stake in shares of Healthpeak Properties by 274.6% during the fourth quarter. Parallel Advisors LLC now owns 4,072 shares of the real estate investment trust’s stock valued at $54,000 after acquiring an additional 2,985 shares during the period. Allspring Global Investments Holdings LLC grew its stake in shares of Healthpeak Properties by 42.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 5,750 shares of the real estate investment trust’s stock worth $70,000 after purchasing an additional 1,712 shares during the last quarter. Envestnet Portfolio Solutions Inc. bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth approximately $124,000. Quadrant Capital Group LLC lifted its stake in Healthpeak Properties by 645.4% during the fourth quarter. Quadrant Capital Group LLC now owns 9,646 shares of the real estate investment trust’s stock valued at $128,000 after purchasing an additional 8,352 shares during the last quarter. Finally, Stratos Wealth Partners LTD. acquired a new position in Healthpeak Properties in the fourth quarter worth approximately $134,000. Institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.